PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Jiang C et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. 1998 Nature pmid:9422509
Tan W et al. Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons. 1998 J. Neurophysiol. pmid:9463448
Nagoshi H et al. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. 1998 Circ. Res. pmid:9468191
Nagy L et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. 1998 Cell pmid:9568715
Yang VW et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. 1998 Cancer Res. pmid:9563494
Mooney JJ et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). 1998 Biol. Psychiatry pmid:9564442
Souza SC et al. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. 1998 Diabetes pmid:9568706
Tontonoz P et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. 1998 Cell pmid:9568716
Austin S et al. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. 1998 Cell Growth Differ. pmid:9543393
Fukushima S et al. [Pharmaceutical and pharmacological development of antitumor prostaglandins]. 1998 Nippon Rinsho pmid:9549353
Akarsu ES et al. Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2. 1998 Epilepsy Res. pmid:9551845
Hayaishi O [Prostaglandins and sleep]. 1998 Nippon Rinsho pmid:9503823
Urade Y [Gene engineering studies on sleep]. 1998 Nippon Rinsho pmid:9503856
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Giardiello FM et al. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. 1998 Dig. Dis. Sci. pmid:9512123
Rossi AG et al. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. 1998 J. Immunol. pmid:9531319
Morrow JD et al. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. 1998 Arch. Biochem. Biophys. pmid:9578611
Wright DH et al. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. 1998 Br. J. Pharmacol. pmid:9579725
Liao CH et al. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets. 1998 Jpn. J. Pharmacol. pmid:9541276
Crider JY et al. Use of a semi-automated, robotic radioimmunoassay to measure cAMP generated by activation of DP-, EP2-, and IP-prostaglandin receptors in human ocular and other cell types. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9758211
Huszár E et al. Elevated circulating adenosine level potentiates antigen-induced immediate bronchospasm and bronchoconstrictor mediator release in sensitized guinea pigs. 1998 J. Allergy Clin. Immunol. pmid:9802380
Matsushita N et al. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. 1998 Jpn. J. Pharmacol. pmid:9804057
Ohtani-Fujita N et al. p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2. 1998 Biochem. Biophys. Res. Commun. pmid:9792828
Ma H et al. Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue. 1998 J. Biol. Chem. pmid:9804768
Tada K et al. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions. 1998 J. Immunol. pmid:9794438
Tsai WJ et al. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina. 1998 Eur. J. Pharmacol. pmid:9617759
Arakida Y et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors. 1998 J. Pharmacol. Exp. Ther. pmid:9808690
Nishino S et al. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. 1998 Psychiatry Res pmid:9657418
Madhu C et al. Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro. 1998 J Ocul Pharmacol Ther pmid:9811228
Thomson AM et al. Sequence, catalytic properties and expression of chicken glutathione-dependent prostaglandin D2 synthase, a novel class Sigma glutathione S-transferase. 1998 Biochem. J. pmid:9657971
Szczeklik A et al. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. 1998 Am. J. Respir. Crit. Care Med. pmid:9769277
Kalgutkar AS et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 1998 Science pmid:9596581
Fiebich BL et al. Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. 1998 J. Neural Transm. Suppl. pmid:9850935
Christman BW Lipid mediator dysregulation in primary pulmonary hypertension. 1998 Chest pmid:9741570
Takahashi S et al. Localization of a cyclopentenone prostaglandin to the endoplasmic reticulum and induction of BiP mRNA. 1998 Biochem. J. pmid:9742210
Csala M et al. Prostaglandin-independent stimulation of interleukin-6 production by fibrinogen degradation product D in perfused murine liver. 1998 Scand. J. Immunol. pmid:9743211
Kilunga Kubata B et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. 1998 J. Exp. Med. pmid:9743538
Torii SI et al. Thiazolidinedione induces the adipose differentiation of fibroblast-like cells resident within bovine skeletal muscle. 1998 Cell Biol. Int. pmid:10328850
Onoe H [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. 1998 Nippon Yakurigaku Zasshi pmid:10202759
Marx N et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. 1998 Am. J. Pathol. pmid:9665460
Seckl J Mechanisms of fetal origins of health problems in adults need to be investigated. 1998 BMJ pmid:9665923
Rosenbaum SE and Greenberg AS The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. 1998 Mol. Endocrinol. pmid:9717841
Yoshida T et al. Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer. 1998 Surg. Today pmid:9697269
Terao A et al. Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. 1998 J. Neurosci. pmid:9698346
Scammell T et al. Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9636223
Moon TC et al. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. 1998 Cell. Immunol. pmid:9636692
Iijima K et al. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells. 1998 Biochem. Biophys. Res. Commun. pmid:9642130
Fujitani Y et al. [Sleep-promoting substances]. 1998 Nihon Ronen Igakkai Zasshi pmid:10064966
O'Sullivan S et al. Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine. 1998 Thorax pmid:10195076
Longo WE et al. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. 1998 Prostaglandins Other Lipid Mediat. pmid:9990676
Löhrke B et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. 1998 J. Endocrinol. pmid:9834460
Haberl C et al. Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity. 1998 Mediators Inflamm. pmid:9836493
Longo WE et al. The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation. 1998 Mediators Inflamm. pmid:9836494
Takafuji S et al. Release of granule proteins from human eosinophils stimulated with mast-cell mediators. 1998 Allergy pmid:9821474
Shichijo M et al. The effects of anti-asthma drugs on mediator release from cultured human mast cells. 1998 Clin. Exp. Allergy pmid:9824389
Ahn SG et al. The role of c-Myc and heat shock protein 70 in human hepatocarcinoma Hep3B cells during apoptosis induced by prostaglandin A2/Delta12-prostaglandin J2. 1998 Biochim. Biophys. Acta pmid:9824682
Petersen LJ and Skov PS The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions. 1999 Inflamm. Res. pmid:10563469
Wise H Characterization of chimeric prostacyclin/prostaglandin D(2) receptors. 1999 Eur. J. Pharmacol. pmid:10611468
Lin Q et al. Ligand selectivity of the peroxisome proliferator-activated receptor alpha. 1999 Biochemistry pmid:9890897
Vaidya S et al. 15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. 1999 J. Immunol. pmid:10570310
Chou TC and Li CY Inhibitory mechanisms of dantrolene on platelet aggregation. 1999 Thromb. Res. pmid:10593433
Sarraf P et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer. 1999 Mol. Cell pmid:10394368
Jang MK et al. Regulation of ferritin light chain gene expression by oxidized low-density lipoproteins in human monocytic THP-1 cells. 1999 Biochem. Biophys. Res. Commun. pmid:10558912
Heneka MT et al. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. 1999 J. Neuroimmunol. pmid:10695726
Herschman HR Function and regulation of prostaglandin synthase 2. 1999 Adv. Exp. Med. Biol. pmid:10667302
Murakami M et al. Regulation of prostaglandin, leukotriene, and platelet-activating factor metabolism in mast cells. 1999 Adv. Exp. Med. Biol. pmid:10667307
Charpigny G et al. Correlation of increased concentration of ovine endometrial cyclooxygenase 2 with the increase in PGE2 and PGD2 in the late luteal phase. 1999 J. Reprod. Fertil. pmid:10690199
Satoh H et al. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function. 1999 Biochem. Biophys. Res. Commun. pmid:9920814
Conti C et al. Antiviral effect of hyperthermic treatment in rhinovirus infection. 1999 Antimicrob. Agents Chemother. pmid:10103186
Shichijo M et al. Role of cyclic 3',5'-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. 1999 J. Allergy Clin. Immunol. pmid:10329844
Eguchi N et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:9892701
Cordoba-Rodriguez R et al. Calcium regulation of a slow post-spike hyperpolarization in vagal afferent neurons. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10393875
Bishop-Bailey D and Hla T Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. 1999 J. Biol. Chem. pmid:10358055
Mita H et al. Generation of thromboxane A2 from highly purified human sinus mast cells after immunological stimulation. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10359019
Herbertsson H et al. The 650-kDa 12(S)-hydroxyeicosatetraenoic acid binding complex: occurrence in human platelets, identification of hsp90 as a constituent, and binding properties of its 50-kDa subunit. 1999 Arch. Biochem. Biophys. pmid:10375396
Rouaud C et al. The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation. 1999 Br. J. Pharmacol. pmid:10051118
Makker HK et al. Airway endothelin levels in asthma: influence of endobronchial hypertonic saline challenge. 1999 Clin. Exp. Allergy pmid:10051729
Marx N et al. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. 1999 Arterioscler. Thromb. Vasc. Biol. pmid:10073956
Walch L et al. Prostanoid receptors involved in the relaxation of human pulmonary vessels. 1999 Br. J. Pharmacol. pmid:10193765
Norel X et al. Prostanoid receptors involved in the relaxation of human bronchial preparations. 1999 Br. J. Pharmacol. pmid:10193766
Chen Y et al. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. 1999 J. Biol. Chem. pmid:10196163
Koro O et al. Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis. 1999 J. Allergy Clin. Immunol. pmid:10200017
Petrova TV et al. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10200320
Brambilla R et al. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. 1999 Br. J. Pharmacol. pmid:10188963
Clay CE et al. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. 1999 Carcinogenesis pmid:10506103
Valmaseda A et al. Opposite regulation of PPAR-alpha and -gamma gene expression by both their ligands and retinoic acid in brown adipocytes. 1999 Mol. Cell. Endocrinol. pmid:10509805
Reddy ST et al. Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. 1999 Biochem. Biophys. Res. Commun. pmid:10548515
Stillman BA et al. Importance of the extracellular domain for prostaglandin EP(2) receptor function. 1999 Mol. Pharmacol. pmid:10462542
Wright DH et al. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. 1999 Eur. J. Pharmacol. pmid:10448933
Su CG et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. 1999 J. Clin. Invest. pmid:10449430
Miadonna A et al. Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours. 1999 Clin. Exp. Allergy pmid:10383595
Hayaishi O Prostaglandin D2 and sleep--a molecular genetic approach. 1999 J Sleep Res pmid:10389108
Salińska E et al. Role of Ca2+ release from ryanodine stores in generation of NMDA-induced Ca2+ signal in rabbit hippocampus. 1999 Ross Fiziol Zh Im I M Sechenova pmid:10389178
Pelton PD et al. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. 1999 Biochem. Biophys. Res. Commun. pmid:10425206
Chinery R et al. Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. 1999 Cancer Res. pmid:10364000
Crider JY et al. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. 1999 Br. J. Pharmacol. pmid:10369474
Chan CL and Lau HY Prostanoid DP receptor activation inhibits anti-IgE induced histamine release from rat peritoneal mast cells. 1999 Inflamm. Res. pmid:10350148
Urade Y and Hayaishi O Prostaglandin D2 and sleep regulation. 1999 Biochim. Biophys. Acta pmid:9989291
Sakamoto H et al. Effect of intracellular glutathione on the production of prostaglandin D2 in RBL-2H3 cells oxidized by tert-butyl hydroperoxide. 1999 J. Biochem. pmid:9880802
Obata T et al. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. 1999 Clin. Exp. Allergy pmid:10457118